Zinecard

Active Ingredient(s): Dexrazoxane
FDA Approved: May 26, 1995
Pharm Company: PHARMACIA AND UPJOHN
Category: Cancer

Welcome to the Zinecard information hub. Scroll down to read supplemental details and discuss this drug.

Zinecard Overview

Dexrazoxane hydrochloride (Zinecard by Pfizer in USA and Canada; Cardioxane by Novartis for EU and other countries) is a cardioprotective agent. Uses It has been used to protect the heart against the cardiotoxic side effects of anthracyclines,[1] such as doxorubicin.[2] However, in July 2011 the US Food and Drug Administration released a statement restricting use only in adult patients with breast cancer who have received > 300 mg/m2 doxorubicin (an anthracycline) or > 540 mg/m2 epirubicin...

Read more Zinecard Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: http://en.wikipedia.org/wiki/Dexrazoxane

Recent Zinecard Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Other drugs which contain Dexrazoxane or a similar ingredient: (2 results)